AURA Aura Biosciences, Inc.
Healthcare$7.61+0.13%ClosedMarket Cap: $488.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.78
P/S
0.00
EV/EBITDA
-3.63
DCF Value
$0.67
FCF Yield
-18.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-78.1%
ROA
-81.6%
ROIC
-95.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-34.9M | $-33.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-27.2M | $-25.6M | $— | — |
| FY null | $0.00 | NaN% | $-112.8M | $-106.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-27.9M | $-26.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-28.6M | $-27.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-29.0M | $-27.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-27.8M | $-25.8M | $— | — |
| FY null | $0.00 | NaN% | $-96.1M | $-86.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-23.2M | $-21.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-22.8M | $-20.3M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-22.3M | $-19.7M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-24.8M | $-22.1M | $-0.50 | — |